Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Nano-X Imaging Ltd. (NASDAQ: NNOX) and certain of its officers, the New York-based investor-rights firm announced on June 18, 2026. The suit alleges investor harm and seeks to recover damages on behalf of affected shareholders.
What the Lawsuit Targets
The action names Nano-X Imaging and specific company officers as defendants, though the source does not identify those individuals by name. Class action suits of this type typically consolidate claims from multiple investors who allege they suffered losses due to materially false or misleading statements — but the source does not specify the underlying allegations in detail. Bronstein, Gewirtz & Grossman describes itself as a nationally recognized investor-rights law firm.
What Investors Should Know
The firm's announcement is directed at Nano-X Imaging investors and carries an explicit call to act, a standard step in the class action process that allows shareholders who believe they were harmed to join the litigation as lead plaintiffs. The source does not disclose a class period, specific damages sought, or the price range over which investors may have purchased NNOX shares.
For NNOX shareholders, the filing is a signal to review their positions and consult legal counsel. Class action participation windows are typically governed by court-imposed deadlines, and investors who delay risk losing the opportunity to serve as lead plaintiff — a role that carries more influence over settlement negotiations.
The Broader Pattern
Securities class actions against technology and medical-imaging companies are a familiar feature of the litigation landscape, particularly when share prices decline sharply after disclosures that plaintiffs argue should have been made earlier. Whether Nano-X Imaging fits that pattern here cannot be determined from the information provided in this announcement alone.
Nano-X Imaging trades on the Nasdaq under the ticker NNOX. Investors seeking more information on the lawsuit or their potential eligibility to participate should contact Bronstein, Gewirtz & Grossman LLC directly, as the firm is actively soliciting shareholder inquiries.